Quintiles
North America, North Carolina, United States, Durham
Description
Quintiles is a provider of biopharmaceutical development and commercial outsourcing services for drugs on the market.
Investor Profile
Quintiles has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series E, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Biotechnology, Biopharma, Therapeutics.
Stage Focus
- Series Unknown (25%)
- Series E (25%)
- Series B (25%)
- Series D (25%)
Country Focus
- United States (75%)
- Israel (25%)
Industry Focus
- Biotechnology
- Biopharma
- Therapeutics
- Pharmaceutical
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Quintiles frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
What are some of recent deals done by Quintiles?
Find More Investors Like Quintiles
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
